Michael Elliot Shankman - Chief Financial Officer at Lexaria Bioscience Corp.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
LEXX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Michael Elliot Shankman since 12 Aug 2025

Reported holdings for Michael Elliot Shankman in Lexaria Bioscience Corp.

Form 4 holding Chief Financial Officer

Lexaria Bioscience Corp.

Security class
Stock Options
Shares / value
100,000
Estimated value
$122,000
Report date
15 May 2025
Price
$1.22
Ownership
Direct
Underlying class
Common Shares
Underlying amount
100,000

Transaction history for Michael Elliot Shankman in Lexaria Bioscience Corp.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .